Related Experiment Video
Updated: Feb 16, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing
Linlin Chen1, Chunling Luo1, Lei Shen2
1Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Abstract:
Dysregulated alternative splicing events have been implicated in many types of cancer, but the underlying molecular mechanisms remain unclear. Here, we observe that the splicing factor SRSF1 regulates DBF4B exon6 splicing by specifically binding and promoting its inclusion. Knockdown of the exon6-containing isoform (DBF4B-FL) significantly inhibits the tumorigenic potential of colon cancer cells in vitro and in mice, and SRSF1 inactivation phenocopies DBF4B-FL depletion. DBF4B-FL and SRSF1 are required for cancer cell proliferation and for the maintenance of genomic stability. Overexpression of DBF4B-FL can protect against DNA damage induced by SRSF1 knockdown and rescues growth defects in SRSF1-depleted cells. Increased DBF4B exon6 inclusion parallels SRSF1 upregulation in clinical colorectal cancer samples. Taken together, our findings identify SRSF1 as a key regulator of DBF4B pre-mRNA splicing dysregulation in colon cancer, with possible clinical implications as candidate prognostic factors in cancer patients.
Insights
The splicing factor SRSF1 promotes DBF4B exon6 inclusion, crucial for colon cancer cell proliferation and genomic stability. SRSF1 and DBF4B-FL are potential prognostic factors in colorectal cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Alternative splicing dysregulation is linked to cancer, but mechanisms are unclear.
- The splicing factor SRSF1's role in cancer is under investigation.
Purpose of the Study:
- To investigate the role of SRSF1 in regulating DBF4B splicing in colon cancer.
- To determine the functional significance of the DBF4B exon6-containing isoform (DBF4B-FL) in tumorigenesis.
Main Methods:
- Investigated SRSF1 binding and regulation of DBF4B exon6 splicing.
- Utilized in vitro and in vivo models (colon cancer cells, mice) to assess the impact of DBF4B-FL and SRSF1.
- Analyzed clinical colorectal cancer samples for SRSF1 and DBF4B exon6 inclusion levels.
Main Results:
- SRSF1 specifically promotes DBF4B exon6 inclusion.
- DBF4B-FL and SRSF1 are essential for colon cancer cell proliferation and genomic stability.
- SRSF1 inactivation mimics DBF4B-FL depletion effects.
- DBF4B-FL overexpression rescues growth defects and DNA damage from SRSF1 knockdown.
- Increased DBF4B exon6 inclusion correlates with SRSF1 upregulation in clinical colorectal cancer.
Conclusions:
- SRSF1 is a key regulator of DBF4B pre-mRNA splicing in colon cancer.
- SRSF1-mediated DBF4B exon6 splicing is critical for colon cancer progression.
- SRSF1 and DBF4B-FL represent potential prognostic biomarkers for colorectal cancer.
Related Concept Videos
RNA Splicing
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Negative Regulator Molecules
Abnormal Proliferation

